Lam Research (NASDAQ:LRCX) Price Target Raised to $315.00

Lam Research (NASDAQ:LRCX) had its price target hoisted by JPMorgan Chase & Co. from $300.00 to $315.00 in a research report released on Thursday, MarketBeat reports. They currently have an overweight rating on the semiconductor company’s stock.

Several other equities research analysts have also recently issued reports on LRCX. Zacks Research cut shares of Lam Research from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. TD Cowen increased their target price on shares of Lam Research from $290.00 to $340.00 and gave the company a “buy” rating in a research report on Thursday. KeyCorp restated a “sector weight” rating on shares of Lam Research in a research report on Thursday, January 29th. Royal Bank Of Canada upped their price objective on shares of Lam Research from $290.00 to $310.00 and gave the company an “outperform” rating in a research note on Thursday. Finally, Rothschild & Co Redburn increased their price objective on shares of Lam Research from $225.00 to $265.00 and gave the company a “buy” rating in a report on Friday, February 6th. Twenty-six equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $284.49.

Lam Research Price Performance

Shares of Lam Research stock opened at $267.78 on Thursday. The stock has a market capitalization of $334.40 billion, a P/E ratio of 50.52, a PEG ratio of 2.69 and a beta of 1.78. The business has a 50 day simple moving average of $234.99 and a two-hundred day simple moving average of $198.24. Lam Research has a 12 month low of $68.53 and a 12 month high of $275.84. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.54 and a quick ratio of 1.61.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.11. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.The firm had revenue of $5.84 billion for the quarter, compared to analyst estimates of $5.70 billion. During the same period in the previous year, the company posted $1.04 earnings per share. The business’s revenue was up 23.8% on a year-over-year basis. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. As a group, analysts predict that Lam Research will post 5.43 EPS for the current fiscal year.

Lam Research Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th were given a $0.26 dividend. The ex-dividend date of this dividend was Wednesday, March 4th. This represents a $1.04 dividend on an annualized basis and a yield of 0.4%. Lam Research’s dividend payout ratio is presently 19.62%.

Insiders Place Their Bets

In other news, insider Ava Harter sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $232.50, for a total value of $930,000.00. Following the transaction, the insider directly owned 54,705 shares in the company, valued at approximately $12,718,912.50. This represents a 6.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Eric Brandt sold 35,000 shares of the stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the transaction, the director directly owned 253,705 shares of the company’s stock, valued at $57,235,848. The trade was a 12.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 130,886 shares of company stock valued at $29,658,802 over the last 90 days. 0.31% of the stock is owned by company insiders.

Institutional Trading of Lam Research

A number of institutional investors and hedge funds have recently added to or reduced their stakes in LRCX. Norges Bank purchased a new position in shares of Lam Research during the fourth quarter worth $3,645,427,000. Price T Rowe Associates Inc. MD lifted its stake in Lam Research by 352.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company’s stock worth $2,344,347,000 after acquiring an additional 10,666,540 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in Lam Research by 781.3% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 11,340,865 shares of the semiconductor company’s stock valued at $1,518,542,000 after acquiring an additional 10,053,978 shares during the period. Franklin Resources Inc. boosted its holdings in Lam Research by 57.0% during the 4th quarter. Franklin Resources Inc. now owns 10,110,560 shares of the semiconductor company’s stock valued at $1,730,724,000 after acquiring an additional 3,671,073 shares during the period. Finally, Corient Private Wealth LLC grew its position in Lam Research by 235.5% in the 4th quarter. Corient Private Wealth LLC now owns 5,199,441 shares of the semiconductor company’s stock valued at $890,040,000 after acquiring an additional 3,649,553 shares in the last quarter. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research News Roundup

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Q3 results beat expectations (EPS $1.47, revenue $5.84B) and management gave strong FY guidance tied to AI demand — investors view this as confirmation of a multi-year WFE upcycle. Earnings & press coverage
• Positive Sentiment: Major analysts have lifted price targets across the board (examples: TD Cowen $340, Susquehanna $385, JPMorgan $315, BofA $330), signaling upgraded revenue and margin forecasts driven by AI memory and logic chip spending. Analyst target upgrades
• Positive Sentiment: Several bank research notes reiterated buy/outperform ratings and sizable upside, reinforcing momentum and prompting institutional buyers to add exposure. Deutsche Bank price target raise
• Neutral Sentiment: Broad market action (Dow slip while Nasdaq gains) and strong moves in other chip names (Intel, AMD, Arm) contributed to sector flow into semiconductor-equipment names including LRCX. Market breadth coverage
• Neutral Sentiment: Not all firms moved to buy: a few kept neutral/equal-weight stances (e.g., Morgan Stanley, BNP Paribas), showing some analysts want to see more cycles of delivery before upgrading conviction. Morgan Stanley note
• Negative Sentiment: Valuation concerns: commentary and analysis warn the stock reflects a lot of AI upside already — some investors may view multiple and momentum as stretched, which could amplify pullbacks on any growth-slow surprises. Valuation caution analysis

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.